Show simple item record

dc.contributor.authorLiu, Guozheng
dc.date2022-08-11T08:10:46.000
dc.date.accessioned2022-08-23T17:19:35Z
dc.date.available2022-08-23T17:19:35Z
dc.date.issued2017-04-01
dc.date.submitted2017-05-08
dc.identifier.citationMethods Mol Biol. 2017;1565:161-179. doi: 10.1007/978-1-4939-6817-6_14. <a href="https://doi.org/10.1007/978-1-4939-6817-6_14">Link to article on publisher's site</a>
dc.identifier.issn1064-3745 (Linking)
dc.identifier.doi10.1007/978-1-4939-6817-6_14
dc.identifier.pmid28364242
dc.identifier.urihttp://hdl.handle.net/20.500.14038/48107
dc.description.abstractDiffering from the conventional direct-targeting strategy in which a probe or payload is directly loaded onto a targeting molecule that binds to the native target, pretargeting is an improved targeting strategy. It converts the native target to an artificial target specific for a secondary targeting molecule loaded with the probe or payload (effector). The effector is small and does not accumulate in normal tissues, which accelerates the targeting process and generates high target to nontarget ratios. DNA/cDNA analogs can serve as the recognition pair, i.e., the artificial target and the secondary targeting effector. Morpholino oligomers are so far the most investigated and the most successful DNA/cDNA analog recognition pairs for pretargeting. Herein, we describe the pretargeting principles, the pretargeting strategy using Morpholino oligomers, and the preclinical success so far achieved.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=28364242&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttps://doi.org/10.1007/978-1-4939-6817-6_14
dc.subjectAntibody
dc.subjectAntibody modification
dc.subjectIn Vitro and In Vivo targeting evaluation
dc.subjectMorpholino oligomers
dc.subjectPreclinical study
dc.subjectPretargeting
dc.subjectRadiolabeling of Morpholino oligomers
dc.subjectSemiempirical pretargeting model
dc.subjectMolecular Biology
dc.subjectRadiology
dc.titleUse of Morpholino Oligomers for Pretargeting
dc.typeBook Chapter
dc.source.booktitleMethods in molecular biology (Clifton, N.J.)
dc.source.volume1565
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/radiology_pubs/211
dc.identifier.contextkey10133376
html.description.abstract<p>Differing from the conventional direct-targeting strategy in which a probe or payload is directly loaded onto a targeting molecule that binds to the native target, pretargeting is an improved targeting strategy. It converts the native target to an artificial target specific for a secondary targeting molecule loaded with the probe or payload (effector). The effector is small and does not accumulate in normal tissues, which accelerates the targeting process and generates high target to nontarget ratios. DNA/cDNA analogs can serve as the recognition pair, i.e., the artificial target and the secondary targeting effector. Morpholino oligomers are so far the most investigated and the most successful DNA/cDNA analog recognition pairs for pretargeting. Herein, we describe the pretargeting principles, the pretargeting strategy using Morpholino oligomers, and the preclinical success so far achieved.</p>
dc.identifier.submissionpathradiology_pubs/211
dc.contributor.departmentDepartment of Radiology
dc.source.pages161-179


This item appears in the following Collection(s)

Show simple item record